TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 61 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $17,941 | +56.0% | 473 | 0.0% | 0.00% | – |
| Q1 2023 | $11,503 | -16.3% | 473 | 0.0% | 0.00% | – |
| Q4 2022 | $13,736 | -1.9% | 473 | 0.0% | 0.00% | – |
| Q3 2022 | $14,000 | -17.6% | 473 | 0.0% | 0.00% | – |
| Q2 2022 | $17,000 | -15.0% | 473 | 0.0% | 0.00% | – |
| Q1 2022 | $20,000 | -16.7% | 473 | 0.0% | 0.00% | – |
| Q4 2021 | $24,000 | -20.0% | 473 | 0.0% | 0.00% | – |
| Q3 2021 | $30,000 | -11.8% | 473 | 0.0% | 0.00% | – |
| Q2 2021 | $34,000 | -2.9% | 473 | 0.0% | 0.00% | – |
| Q1 2021 | $35,000 | 0.0% | 473 | 0.0% | 0.00% | – |
| Q4 2020 | $35,000 | +34.6% | 473 | 0.0% | 0.00% | – |
| Q3 2020 | $26,000 | -16.1% | 473 | 0.0% | 0.00% | – |
| Q2 2020 | $31,000 | +6.9% | 473 | 0.0% | 0.00% | – |
| Q1 2020 | $29,000 | – | 473 | +7783.3% | 0.00% | – |
| Q3 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 6 | -97.0% | 0.00% | – |
| Q4 2017 | $21,000 | -4.5% | 203 | -1.9% | 0.00% | – |
| Q3 2017 | $22,000 | -33.3% | 207 | -29.6% | 0.00% | – |
| Q2 2017 | $33,000 | +13.8% | 294 | +14.0% | 0.00% | – |
| Q1 2017 | $29,000 | -6.5% | 258 | -10.4% | 0.00% | – |
| Q4 2016 | $31,000 | +40.9% | 288 | +44.0% | 0.00% | – |
| Q3 2016 | $22,000 | -26.7% | 200 | 0.0% | 0.00% | – |
| Q2 2016 | $30,000 | -70.0% | 200 | -71.4% | 0.00% | – |
| Q1 2016 | $100,000 | -6.5% | 700 | 0.0% | 0.00% | – |
| Q4 2015 | $107,000 | -16.4% | 700 | -22.2% | 0.00% | – |
| Q3 2015 | $128,000 | -0.8% | 900 | 0.0% | 0.00% | – |
| Q2 2015 | $129,000 | +22.9% | 900 | +21.6% | 0.00% | – |
| Q1 2015 | $105,000 | +425.0% | 740 | +428.6% | 0.00% | – |
| Q4 2014 | $20,000 | -9.1% | 140 | 0.0% | 0.00% | – |
| Q3 2014 | $22,000 | +10.0% | 140 | 0.0% | 0.00% | – |
| Q2 2014 | $20,000 | -98.4% | 140 | -98.8% | 0.00% | -100.0% |
| Q1 2014 | $1,284,000 | +6.6% | 11,568 | -5.0% | 0.00% | 0.0% |
| Q4 2013 | $1,204,000 | +6.6% | 12,177 | -18.0% | 0.00% | 0.0% |
| Q3 2013 | $1,129,000 | +52.2% | 14,851 | +12.0% | 0.00% | +100.0% |
| Q2 2013 | $742,000 | – | 13,265 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 545,583 | $34,715,000 | 10.89% |
| Murchinson Ltd. | 100,000 | $6,363,000 | 3.16% |
| Eversept Partners, LP | 179,366 | $11,413,059 | 0.79% |
| BRANDES INVESTMENT PARTNERS, LP | 266,560 | $16,962,000 | 0.37% |
| Analyst IMS Investment Management Services Ltd. | 22,755 | $1,447,000 | 0.18% |
| Claret Asset Management Corp | 9,336 | $594,000 | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 344,023 | $21,851,000 | 0.08% |
| Renaissance Technologies | 720,500 | $45,845,000 | 0.06% |
| C M BIDWELL & ASSOCIATES LTD | 1,155 | $73,000 | 0.05% |
| First Trust Direct Indexing L.P. | 3,357 | $214,000 | 0.03% |